Observations on a Milestone Bribery Investigation and Increased Scrutiny of Foreign Companies in China

 

Topics:  Bribery, China, Compliance, Corruption, Due Diligence, FCPA, Foreign Corporations, GlaxoSmithKline, UK Bribery Act

Published In: General Business Updates, Criminal Law Updates, Finance & Banking Updates, International Trade Updates, Science, Computers & Technology Updates

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© McDermott Will & Emery | Attorney Advertising

Don't miss a thing! Build a custom news brief:

Read fresh new writing on compliance, cybersecurity, Dodd-Frank, whistleblowers, social media, hiring & firing, patent reform, the NLRB, Obamacare, the SEC…

…or whatever matters the most to you. Follow authors, firms, and topics on JD Supra.

Create your news brief now - it's free and easy »